Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.11%3.82B | -31.17%990.56M | 18.82%928.65M | 32.60%886.03M | 49.88%1.01B | 70.84%3.56B | 114.17%1.44B | 35.41%781.59M | 60.08%668.2M | 60.90%675.59M |
Cost of revenue | -1.06%2.71B | -40.16%675.48M | 4.12%629.13M | 28.34%657.29M | 51.05%751.88M | 89.61%2.74B | 142.36%1.13B | 49.29%604.22M | 74.92%512.16M | 75.69%497.78M |
Gross profit | 34.39%1.1B | 1.53%315.08M | 68.87%299.52M | 46.59%228.74M | 46.63%260.72M | 28.40%821.57M | 50.50%310.35M | 2.83%177.37M | 25.23%156.04M | 30.22%177.81M |
Operating expense | 38.57%1.06B | 11.32%268.37M | 79.72%300.17M | 53.04%266.41M | 23.27%227.17M | 12.69%766.49M | 41.56%241.09M | -6.30%167.03M | 5.19%174.09M | 10.96%184.29M |
Operating profit | -23.85%41.95M | -32.55%46.72M | -106.28%-650K | -108.76%-37.67M | 617.89%33.55M | 236.61%55.08M | 92.89%69.26M | 279.07%10.35M | 55.88%-18.05M | 78.08%-6.48M |
Net non-operating interest income (expenses) | 32.64%-997K | 0.00%1K | 0 | 104.00%2K | 30.12%-1M | 55.12%-1.48M | 100.03%1K | 0 | -50K | -1.43M |
Non-operating interest income | 0.00%3K | 0.00%1K | --0 | ---- | ---- | -25.00%3K | -50.00%1K | --0 | ---- | ---- |
Non-operating interest expense | --0 | --0 | --0 | ---- | ---- | 108.00%52K | --0 | --0 | ---- | ---- |
Total other finance cost | -30.12%1M | --0 | --0 | --0 | -30.12%1M | -56.33%1.43M | --0 | --0 | --0 | --1.43M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 69.48%-4.8M | 0 | 0 | -14,900.00%-4.8M | 0 | 84.49%-15.73M | 0 | -160K | -32K | -15.53M |
Less:Other special charges | -69.48%4.8M | --0 | --0 | ---- | ---- | --15.73M | --0 | --160K | --32K | --15.53M |
Other non-operating income (expenses) | 374.27%2.77M | 9,590.91%3.2M | 575.90%790K | -984K | -239K | 979.63%583K | 33K | -166K | ||
Income before tax | 1.18%38.91M | -27.97%49.91M | -98.59%141K | -149.58%-43.45M | 237.82%32.31M | 126.53%38.46M | 200.77%69.29M | 273.46%10.02M | 57.43%-17.41M | 20.59%-23.44M |
Income tax | 38.62%2.29M | 981.54%573K | 0.00%572K | -972.25%-5M | 973.95%6.14M | -27.86%1.65M | -111.34%-65K | 0.00%572K | 0.00%573K | 0.00%572K |
Net income | -0.50%36.62M | -28.86%49.34M | -104.57%-432K | -113.84%-38.45M | 208.95%26.17M | 125.00%36.81M | 200.03%69.36M | 248.78%9.45M | 56.64%-17.98M | 20.19%-24.02M |
Net income continuous operations | -0.50%36.62M | -28.86%49.34M | -104.56%-431K | -113.84%-38.45M | 208.96%26.17M | 125.00%36.81M | 200.03%69.36M | 248.82%9.45M | 56.64%-17.98M | 20.20%-24.02M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -0.50%36.62M | -28.86%49.34M | -104.57%-432K | -113.84%-38.45M | 208.95%26.17M | 125.00%36.81M | 200.03%69.36M | 248.78%9.45M | 56.64%-17.98M | 20.19%-24.02M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -0.50%36.62M | -28.86%49.34M | -104.57%-432K | -113.84%-38.45M | 208.95%26.17M | 125.00%36.81M | 200.03%69.36M | 248.78%9.45M | 56.64%-17.98M | 20.19%-24.02M |
Gross dividend payment | ||||||||||
Basic earnings per share | -7.85%13.86 | -34.50%18.68 | -103.97%-0.16 | -95.06%-14.61 | 199.30%9.95 | 124.40%15.04 | 198.34%28.52 | 255.60%4.03 | 56.81%-7.49 | 21.23%-10.02 |
Diluted earnings per share | -8.52%13.64 | -30.39%18.6328 | -104.15%-0.1631 | -95.06%-14.61 | 197.70%9.79 | 124.18%14.91 | 192.30%26.7663 | 248.37%3.9313 | 56.81%-7.49 | 21.23%-10.02 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |